Epidemiology and risk factors for serious infections in the stem cell transplant setting

被引：1
作者：
Cordonnier, C.
Maury, S.
机构：
[1] Henri Mondor Univ Hosp, Haematol Dept, F-94000 Creteil, France
[2] Henri Mondor Univ Hosp, Fac Med Paris 12, F-94000 Creteil, France
来源：
BLOOD REVIEWS | 2007年 / 21卷
关键词：
stem cell transplant; infection; invasive fungal infections; viral infections;
D O I：
10.1016/S0268-960X(07)70012-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S39 / S42
页数：4
相关论文
共 16 条
[1]   Tumor necrosis factor-α blockade for the treatment of acute GVHD [J].
Couriel, D ;
Saliba, R ;
Hicks, K ;
Ippoliti, C ;
de Lima, M ;
Hosing, C ;
Khouri, I ;
Andersson, B ;
Gajewski, J ;
Donato, M ;
Anderlini, P ;
Kontoyiannis, DP ;
Cohen, A ;
Martin, T ;
Giralt, S ;
Champlin, R .
BLOOD, 2004, 104 (03) :649-654
[2]   Infectious complications after autologous CD34-selected peripheral blood stem cell transplantation [J].
Crippa, F ;
Holmberg, L ;
Carter, RA ;
Hooper, H ;
Marr, KA ;
Bensinger, W ;
Chauncey, T ;
Corey, L ;
Boeckh, M .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2002, 8 (05) :281-289
[3]   Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning [J].
Fukuda, T ;
Boeckh, M ;
Carter, RA ;
Sandmaier, BM ;
Maris, MB ;
Maloney, DG ;
Martin, PJ ;
Storb, RF ;
Marr, KA .
BLOOD, 2003, 102 (03) :827-833
[4]   Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies [J].
Hebart, H ;
Bollinger, C ;
Fisch, P ;
Sarfati, J ;
Meisner, C ;
Baur, M ;
Loeffler, J ;
Monod, M ;
Latgé, JP ;
Einsele, H .
BLOOD, 2002, 100 (13) :4521-4528
[5]   Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: A matched control study [J].
Junghanss, C ;
Marr, KA ;
Carter, RA ;
Sandmaier, BM ;
Maris, MB ;
Maloney, DG ;
Chauncey, T ;
McSweeney, PA ;
Storb, R .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2002, 8 (09) :512-520
[6]   Incidence of invasive aspergillosis after allogeneic hematopoietic stem cell transplantation with a reduced-intensity regimen compared with transplantation with a conventional regimen [J].
Kojima, R ;
Kami, M ;
Nannya, Y ;
Kusumi, E ;
Sakai, M ;
Tanaka, Y ;
Kanda, Y ;
Mori, S ;
Chiba, S ;
Miyakoshi, S ;
Tajima, K ;
Hirai, HI ;
Taniguchi, S ;
Sakamaki, H ;
Takaue, Y .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (09) :645-652
[7]   Management of CMV infections: recommendations from the infectious diseases working party of the EBMT [J].
Ljungman, P ;
Reusser, P ;
de la Camara, R ;
Einsele, H ;
Engelhard, D ;
Ribaud, P ;
Ward, K ;
Cordonnier, C .
BONE MARROW TRANSPLANTATION, 2004, 33 (11) :1075-1081
[8]  
Marr KA, 2000, BLOOD, V96, P2055
[9]   Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients [J].
Marr, KA ;
Carter, RA ;
Crippa, F ;
Wald, A ;
Corey, L .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (07) :909-917
[10]   Toxoplasmosis after hematopoietic stem cell transplantation [J].
Martino, R ;
Maertens, J ;
Bretagne, S ;
Rovira, M ;
Deconinck, E ;
Ullmann, AJ ;
Held, T ;
Cordonnier, C .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (05) :1188-1194
12